Inhibition of glucosamine-6-PO4 synthesis by salicylate and other anti-inflammatory agents in vitro.
D000893:Anti-Inflammatory Agents; D005944:Glucosamine; D006025:Glycosaminoglycans / Q000378:metabolism*; D066298:In Vitro Techniques; D010653:Phenylbutazone / Q000494:pharmacology*; D010710:Phosphates / Q000378:metabolism*; D012459:Salicylates; D012980:Sodium Salicylate / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D006025:Glycosaminoglycans; D010710:Phosphates; D012459:Salicylates; D010653:Phenylbutazone; D005944:Glucosamine; D012980:Sodium Salicylate
MUCOPOLYSACCHARIDES/metabolism; PHENYLBUTAZONE/pharmacology; PHOSPHATES/metabolism; SODIUM SALICYLATE/pharmacology